Infographic: Next-generation antibodies for therapeutic applications

Advances in antibody engineering have led to the expansion of the use of the next generation of antibodies in therapeutic design, with some commercially approved and many more in preclinical and clinical development. Next-generation antibodies are designed to be more specific and more potent than conventional monoclonal antibodies and include bispecific antibodies (bsAbs), antibody–drug conjugates (ADCs) and nanobodies. This infographic reviews the structure, mechanisms, history and clinical performance of these next-generation antibodies, so you can compare, contrast and select the optimal approach for your drug discovery and development programs. This content was supported by Sino Biological.